Wednesday, October 14, 2020
A new mental health treatment based on psilocybin, the active compound in magic mushrooms, is set to be licensed in the US next year. Some research has shown a long-term decrease in authoritarian leanings in patients even after treatment ends, posing intriguing medical and ethical questions.
Admin's note: Participants in this discussion must follow the site's moderation policy. Profanity will be filtered. Abusive conduct is not allowed.